SCHEMBL4481354

SCHEMBL4481354

CCCC(=O)N(CCN(C)C)c1ccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.40
BACE1 P56817 1/20 0.38
FLT3 P36888 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LTB4R2 Q9NPC1 2/20 0.35
PDGFRB P09619 2/20 0.34
CASP3 P42574 2/20 0.34
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ICMT O60725 1/20 0.33
ALB P02768 1/20 0.33
CETP P11597 2/20 0.33
THRB P10828 1/20 0.33
AURKA O14965 1/20 0.33
PDGFRA P16234 1/20 0.33
KDR P35968 1/20 0.33
AURKB Q96GD4 1/20 0.33
AURKC Q9UQB9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4481348 1.00 TP53 (0.40) TP53BACE1FLT3MEN1KMT2A
SCHEMBL4482260 0.93 BACE1 (0.39) TP53BACE1FLT3PDGFRBCASP3
SCHEMBL4482258 0.93 BACE1 (0.39) TP53BACE1FLT3PDGFRBCASP3
SCHEMBL4498293 0.90 BACE1 (0.38) TP53BACE1FLT3PDGFRBAURKA
SCHEMBL4501664 0.90 TP53 (0.40) TP53MEN1KMT2ALTB4R2CASP3
SCHEMBL4501665 0.90 TP53 (0.40) TP53MEN1KMT2ALTB4R2CASP3
SCHEMBL4498295 0.90 BACE1 (0.38) TP53BACE1FLT3PDGFRBAURKA
SCHEMBL4499508 0.90 BACE1 (0.41) TP53BACE1FLT3MEN1KMT2A
SCHEMBL4494308 0.90 BACE1 (0.41) TP53BACE1FLT3PDGFRBCASP3
SCHEMBL4499513 0.90 BACE1 (0.41) TP53BACE1FLT3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR TP53 681/4885BACE1 1615/4885FLT3 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.